A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer

Clinical trial NCT07230106 · RECRUITING

Trial details

NCT number: NCT07230106
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2025-12-08
Primary completion: 2028-12-01
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.